Linical Co., Ltd. (TYO:2183)
317.00
+1.00 (0.32%)
Mar 6, 2026, 3:30 PM JST
Linical Revenue
Linical had revenue of 1.98B JPY in the quarter ending December 31, 2025, a decrease of -21.77%. This brings the company's revenue in the last twelve months to 9.32B, down -15.38% year-over-year. In the fiscal year ending March 31, 2025, Linical had annual revenue of 10.44B, down -15.19%.
Revenue (ttm)
9.32B
Revenue Growth
-15.38%
P/S Ratio
0.77
Revenue / Employee
15.58M
Employees
598
Market Cap
7.16B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 10.44B | -1.87B | -15.19% |
| Mar 31, 2024 | 12.31B | -209.00M | -1.67% |
| Mar 31, 2023 | 12.52B | 961.00M | 8.32% |
| Mar 31, 2022 | 11.56B | 1.28B | 12.41% |
| Mar 31, 2021 | 10.28B | -656.00M | -6.00% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Kohjin Bio | 5.07B |
| Soiken Holdings | 4.58B |
| CellSource | 3.71B |
| MEDINET | 998.00M |
| OncoTherapy Science | 784.00M |
| PRISM BioLab Co.,LTD | 684.61M |
| Chiome Bioscience | 593.29M |
| ADR120S | 40.00M |